Medix Biochemica acquires myPOLS Biotec
All founders of myPOLS Biotec will remain involved in the business following the acquisition
07-Feb-2022 -
Medix Biochemica has acquired 100 percent of the shares of myPOLS Biotec GmbH. As a result of the acquisition, Medix Biochemica broadens its portfolio of molecular diagnostic raw materials for the in vitro diagnostics (“IVD”) industry, complements its scientific expertise and strengthens its ...
acquisitions
in-vitro diagnostics
molecular diagnostics